Transcriptional landscape of the dorsal raphe serotonin neurons rendering stress resiliency

Chihiro Andoh,Suzuka Otani,Takuma Noguchi,Masako Hagiwara,Naoya Nishitani,Hiroyuki Kawai,Yuto Fukui,Masashi Koda,Hinako Morishita,Kento Nomura,Moeka Oki,Harune Hori,Hisashi Shirakawa,Shuji Kaneko,Kazuki Nagayasu
DOI: https://doi.org/10.1101/2024.03.21.586199
2024-03-25
Abstract:Major depressive disorder (MDD) is a serious and large social problem, yet the pathophysiology of MDD and the action mechanism of antidepressants are still poorly understood. A number of studies have reported that activation and inactivation of serotonin neurons in the dorsal raphe nucleus (DRN) cause antidepressant-like effects and depressive-like behaviors, respectively. Also, their physiological neural activities are increased when mice were chronically administered an SSRI and decreased in mice exposed to chronic social defeat stress (CSDS), a mouse model of depression. However, the molecular mechanism underlying these neural activity changes in DRN serotonin neurons remains unclear. In this study, we performed a DRN serotonin neuron-specific comprehensive gene expression analysis by using Translating Ribosome Affinity Purification (TRAP) technology in both chronic SSRI-treated mice as a model of antidepressant treatment and CSDS mice as a model of depression. It revealed that many gene expression changes were the opposite between SSRI-treated mice and CSDS-susceptible mice. Among these, we identified S100a10 as a prodepressive gene in DRN serotonin neurons, and we found that Interleukin-4 (IL-4) – Signal Transducer and Activator of Transcription 6 (STAT6) pathway and 5-HT receptor were the upstream and downstream molecules of S100a10, respectively. Our findings provide insights into molecular mechanisms underlying the action of antidepressants and stress resiliency.
Pharmacology and Toxicology
What problem does this paper attempt to address?